Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (40)COVID-19 (36)

Type

TypeGuidance (4950)Indicators (319)News (350)NICE advice (498)Quality standards (256)Research recommendations (1785)

Status

StatusAwaiting development (335)Discontinued (445)In consultation (15)In development (445)Published (2570)Topic prioritisation (384)

Last updated

Last updatedLast 3 months (208)Last 6 months (383)Last year (705)Last 3 years (1442)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (27)Antimicrobial resistance guidance (2)Cancer service guidelines (10)Clinical guidelines (392)COVID-19 rapid guidelines (27)Diagnostics guidance (88)Health technology evaluations (63)HealthTech guidance (767)Highly specialised technologies guidance (48)Interventional procedures guidance (1006)Medical technologies guidance (149)Medicines practice guidelines (5)NICE guidelines (579)Public health guidelines (89)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2305)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)NICE reviews (2)

Showing 2356 to 2370 of 8904 results

Sort by

Lebrikizumab for treating atopic dermatitis in children [TSID12133]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Eptinezumab for preventing cluster headache attacks TSID 12087
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Linaclotide acetate for treating functional constipation in people 6 to 17 years [TSID12125]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Cefepime–enmetazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia TS ID 12035
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Human immunoglobulin with recombinant human hyaluronidase for maintenance treatment of multifocal motor neuropathy in people of any age TSID 12033
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation

Previous page
1
…
156
157
Current page 158
159
160
…
594
Page 158 of 594
Next page

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2026. All rights reserved. Subject to Notice of rights.